Marijuana compound treats schizophrenia with few side effects

Clinical trial
Time Magazine (US)
Wednesday, May 30, 2012

cannabidiolA compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Unlike the main ingredient in marijuana, THC, which can produce psychotic reactions and may worsen schizophrenia, cannabidiol (CBD) has antipsychotic effects, according to previous research in both animals and humans.